Results 61 to 70 of about 3,272 (188)
Interdisciplinary Toxicology, 2018 Mechlorethamine (HN2) is an alkylating agent and sulfur mustard gas mimetic which is also used in anticancer therapy. HN2 is associated with skin inflammation and blistering which can lead to secondary infections.
Benedette J. Cuffari +3 more
semanticscholar +1 more source
CARBON DOTS: Bioimaging and Anticancer Drug Delivery
Chemistry – A European Journal, Volume 30, Issue 19, April 2, 2024.This review explores Carbon Dots (CDs) in cancer treatment, highlighting their synthesis, bioimaging applications, and role in drug delivery. The review details potential barriers to drug delivery, and details recent studies and developments, with a focus on the use of CDs as nanocarriers in drug delivery systems designed for the delivery of ...
Michał Bartkowski +4 more
wiley +1 more source
The Clinical Respiratory Journal, Volume 18, Issue 3, March 2024.This may be the first reported case with high PD‐L1 expression in primary pulmonary histiocytic sarcoma who may benefit from immunotherapy. Routine PD‐L1 expression detection is recommended for histiocytic sarcoma patients especially those who got advanced cancer.
Yuanjie Lin +3 more
wiley +1 more source
Journal of Veterinary Internal Medicine, Volume 38, Issue 1, Page 308-315, January/February 2024.Abstract Background Hypercalcemia of malignancy (HM) secondary to lymphoma in dogs has the potential to cause renal injury. Hypothesis/Objectives Characterize outcomes related to acute kidney injury (AKI) secondary to HM. We hypothesized that dogs do suffer AKI regardless of HM severity at the time of lymphoma diagnosis or relapse.
Alyssa A. Strumpf +2 more
wiley +1 more source
Successful treatment of lymphomatoid papulosis with chlormethine gel
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 6, Page 826-827, June 2024.
Tassilo Dege +4 more
wiley +1 more source
Erfolgreiche Behandlung einer lymphomatoiden Papulose mit Chlormethin‐Gel
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 22, Issue 6, Page 826-828, June 2024.
Tassilo Dege +4 more
wiley +1 more source
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
Blood and Lymphatic Cancer: Targets and Therapy, 2011 Prathima Prodduturi, James O ArmitageUniversity of Nebraska Medical Center, Omaha, NE, USAAbstract: Early-stage Hodgkin’s lymphoma which includes patients with Ann Arbor stages I or II, accounts for more than 50% of all cases of the illness and
Armitage JO, Prodduturi P
doaj
JAMA dermatology, 2013 OBJECTIVE To evaluate the efficacy and safety of a novel mechlorethamine hydrochloride, 0.02%, gel in mycosis fungoides. DESIGN Randomized, controlled, observer-blinded, multicenter trial comparing mechlorethamine, 0.02%, gel with mechlorethamine, 0.02%,
S. Lessin +16 more
semanticscholar +1 more source
Treatment of lower torso stages I and Ii Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone [PDF]
, 1990 Stanley S. Givens +3 more
openalex +1 more source
The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamine [PDF]
, 2000 John P.H. Wijen
openalex +1 more source